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BACKGROUND: Exercise promotes metabolic remodeling in the heart, which 
is associated with physiological cardiac growth; however, it is not known 
whether or how physical activity–induced changes in cardiac metabolism 
cause myocardial remodeling. In this study, we tested whether exercise-
mediated changes in cardiomyocyte glucose metabolism are important for 
physiological cardiac growth.
METHODS: We used radiometric, immunologic, metabolomic, and 
biochemical assays to measure changes in myocardial glucose metabolism 
in mice subjected to acute and chronic treadmill exercise. To assess the 
relevance of changes in glycolytic activity, we determined how cardiac-
specific expression of mutant forms of 6-phosphofructo-2-kinase/fructose-
2,6-bisphosphatase affect cardiac structure, function, metabolism, and gene 
programs relevant to cardiac remodeling. Metabolomic and transcriptomic 
screenings were used to identify metabolic pathways and gene sets regulated 
by glycolytic activity in the heart.
RESULTS: Exercise acutely decreased glucose utilization via glycolysis by 
modulating circulating substrates and reducing phosphofructokinase activity; 
however, in the recovered state following exercise adaptation, there was an 
increase in myocardial phosphofructokinase activity and glycolysis. In mice, 
cardiac-specific expression of a kinase-deficient 6-phosphofructo-2-kinase/
fructose-2,6-bisphosphatase transgene (GlycoLo mice) lowered glycolytic rate 
and regulated the expression of genes known to promote cardiac growth. 
Hearts of GlycoLo mice had larger myocytes, enhanced cardiac function, 
and higher capillary-to-myocyte ratios. Expression of phosphatase-deficient 
6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase in the heart (GlycoHi 
mice) increased glucose utilization and promoted a more pathological form 
of hypertrophy devoid of transcriptional activation of the physiological cardiac 
growth program. Modulation of phosphofructokinase activity was sufficient to 
regulate the glucose–fatty acid cycle in the heart; however, metabolic inflexibility 
caused by invariantly low or high phosphofructokinase activity caused modest 
mitochondrial damage. Transcriptomic analyses showed that glycolysis regulates 
the expression of key genes involved in cardiac metabolism and remodeling.
CONCLUSIONS: Exercise-induced decreases in glycolytic activity stimulate 
physiological cardiac remodeling, and metabolic flexibility is important for 
maintaining mitochondrial health in the heart.
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Exercise promotes cardiovascular wellness,
1 aug-
ments musculoskeletal function,2 and lengthens 
lifespan.3 These salutary effects of exercise are 
dependent on the ability of the body to adapt to re-
current bouts of physical activity. Cumulative adapta-
tion of the circulatory, pulmonary, and musculoskel-
etal systems augments exercise capacity,4 which is 
the strongest indicator of cardiovascular health and a 
robust predictor of mortality.5 Cardiovascular adapta-
tions to exercise are particularly critical to enable ad-
equate oxygen and nutrient delivery to peripheral tis-
sues, and they help preserve circulatory system health 
with age.6,7 Physiological cardiac growth attributable 
to exercise training is a key component of these car-
diovascular adaptations and contributes not only to 
exercise capacity, but also to cardioprotection.8 Nev-
ertheless, the mechanisms by which regular exercise 
triggers and sustains cardiac adaptation remain un-
clear. Understanding how exercise promotes healthy 
cardiac remodeling could provide the knowledge re-
quired to delay the progression of heart disease or re-
verse tissue pathology.
Previous studies have identified signaling pathways 
and gene programs essential for cardiac adaptation.9,10 
For example, C/EBPβ and CITED4 are known to be criti-
cal for regulating the transcriptional programs that in-
stigate cardiac growth11–13; however, the mechanisms 
by which such transcriptional programs are activat-
ed with exercise are unclear. In tissues such as skel-
etal muscle, adaptive changes in gene expression are 
thought to be initiated by the repetitive bouts of met-
abolic stress triggered by strenuous physical activity.2 
Although it follows that the heart should conform to 
this paradigm, this has not been tested and it remains 
unclear which metabolic pathways and flux control 
steps may be important to provoke tissue adaptation 
to exercise.
In this study, we examined exercise-induced changes 
in glucose metabolism and their relationship to cardiac 
remodeling. We provide evidence that exercise regu-
lates the activity of myocardial phosphofructokinase 1 
(PFK1) and that the resulting changes in metabolism are 
sufficient to activate a transcriptional program influenc-
ing exercise-induced cardiac growth. Nonetheless, our 
data also indicate that chronically low or high relative 
levels of glycolysis, such as occurs in type 2 diabetes 
mellitus or heart failure, are damaging to mitochondria. 
These findings suggest that changes in myocardial glu-
cose metabolism, brought about by regular exercise, 
regulate transcriptional programming and physiologi-
cal remodeling of the heart and that maintenance of 
metabolic flexibility is required to preserve mitochon-
drial health.
METHODS
Experimental Animals 
All procedures were approved by the University of Louisville 
Institutional Animal Care and Use Committee. Transgenic 
mice expressing a kinase-deficient (ie, GlycoLo mice) or phos-
phatase-deficient (ie, GlycoHi mice) form of 6-phosphofructo-
2-kinase/fructose-2,6-bisphosphatase (PFK2) under the 
control of the α-myosin heavy chain promoter and wild-type 
(WT) littermates on the FVB/NJ background were used for this 
study.14,15 Adult, male mice were used for all studies, with 
the exception of fructose 2,6,-bisphosphate (F-2,6-P2) mea-
surements in isolated cardiomyocytes, where both male and 
female mice were used. At the conclusion of animal experi-
ments, and after a 6-hour fast, mice were anaesthetized with 
sodium pentobarbital (150 mg/kg, intraperitoneally) and 
euthanized.
Exercise Capacity Testing and Training 
We performed exercise familiarization, capacity testing, and 
training as we previously outlined.16
Clinical Perspective
What Is New?
• Episodic, exercise-induced changes in cardiac 
metabolism appear to be required for healthy, 
physiological growth of the heart.
• In the heart, glucose utilization via glycolysis is 
reduced during exercise and in the early recovery 
period after exercise.
• Low rates of myocardial glycolysis are sufficient to 
activate gene programs that instigate physiological 
cardiac growth.
• Metabolic inflexibility of the heart, such as occurs 
in heart failure and diabetes mellitus, is sufficient to 
diminish mitochondrial function.
• Phosphofructokinase-mediated changes in 
metabolism appear to regulate genes involved in 
processes critical for metabolic remodeling, tran-
scription, cell division, differentiation, cell prolifera-
tion, and contraction.
What Are the Clinical Implications?
• Regular exercise diminishes cardiovascular disease 
risk. Preclinical studies identifying the mechanisms 
by which exercise-induced metabolic changes in 
the heart regulate cardiac growth and health could 
be used to promote healthy cardiac adaptation and 
delay disease progression.
• Identification of genes regulated by metabolism 
could lead to new therapeutic targets to mitigate 
maladaptive cardiac remodeling and heart failure.
• The finding that loss of cardiac metabolic flexibil-
ity promotes mitochondrial dysfunction could be 
important for predicting mitochondrial derange-
ments in patients and for devising personalized 
treatment strategies to improve the metabolic flex-
ibility of the heart.
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Echocardiographic Assessment 
Cardiac function was measured by transthoracic echocardiog-
raphy, as described.17
Measurements of Myocardial Glucose 
Utilization 
Hearts were excised and perfused in nonrecirculating 
Langendorff mode with Krebs-Henseleit buffer (37°C; 5% 
CO2/95% O2; containing in mmol/L: 118.5 NaCl, 25 NaHCO3, 
4.7 KCl, 1.2 MgSO4, 1.2 KH2PO4, 2.5 CaCl2, and 5 glucose; pH 
7.4). Glycolytic flux was assessed by measuring the amount of 
3H2O released through the metabolism of exogenous [5-
3H]
glucose (Perkin Elmer), as described.14,15 Glucose utilization 
was then normalized to total heart weight.
Blood and Plasma Measurements 
Blood glucose and blood lactate were measured via tail clip 
using the Accu-Check Aviva (Roche) and Lactate Plus meter 
(Nova Biomedical), respectively. Free fatty acids were quanti-
fied using a colorimetric enzymatic assay (Sigma-Aldrich), as 
instructed by the manufacturer. Insulin-like growth factor-1 
was quantified using a colorimetric assay (R&D Systems), per 
the manufacturer.
Glycogen Assay
Cardiac glycogen content was determined using a colorimet-
ric assay, as described by the manufacturer (Biovision).
Measurement of F-2,6-P2 Concentration 
Metabolite levels of F-2,6-P2 were measured in isolated ven-
tricular myocytes as outlined previously.14,15
Histology 
After euthanasia, the heart tissue was excised, flushed with 
1 mol/L KCl solution, and fixed in 10% formalin, embedded 
in paraffin, and sectioned at 4 µm. Heart cross sections were 
stained with 4ʹ,6-diamidino-2-phenylindole (Invitrogen) and 
wheat germ agglutinin (ThermoFisher) for quantification of 
cardiomyocyte cross-sectional area. In addition, sections were 
stained with isolectin B4 (Vector Laboratories) to assess capil-
lary density and with Sirius red for fibrosis. Quantitative mea-
surements were determined using Nikon Elements software.
Mitochondrial Function 
Heart mitochondria were isolated and subjected to respira-
tory function assays using the Seahorse XF24, similar to that 
described.18
Protein and mRNA Analysis 
Western blotting and quantitative reverse transcription poly-
merase chain reaction were performed as described in the 
online-only Data Supplement. Lists of antibodies and primers 
are found in the online-only Data Supplement.
Analysis of Cardiac Ultrastructure 
Left ventricular tissue was dissected into 3-mm3 pieces and 
fixed in 2.5% glutaraldehyde overnight. The samples were 
then postfixed in 2% aqueous osmium tetroxide, dehy-
drated in ascending concentrations of ethanol, embedded 
in Araldite 502 (Electron Microscopy Sciences), sectioned 
and mounted on 200-mesh copper grids, and doubly stained 
with uranyl acetate and lead citrate. Ultrastructure was 
examined by using a Phillips CM-10 electron microscope with 
a Laboratory 6 cathode (Phillips Electronic Instruments Co) 
operating at 80 kV.
Metabolomic Analyses 
After a 6-hour fast, hearts were freeze-clamped by using 
Wollenberger forceps ultracooled in liquid nitrogen. Samples 
were stored frozen (–80°C) until metabolite extraction by 
Metabolon, Inc., and subjected to metabolic profiling by 
ultrahigh-performance liquid chromatography/tandem mass 
spectrometry.17 Detailed methods are provided in the online-
only Data Supplement.
Transcriptomic Analyses 
Hearts of male WT, GlycoLo, and GlycoHi mice (15–16 weeks 
of age) were subjected to transcriptomic analysis by using the 
GeneChip Mouse Genome 430 2.0 Array (Affymetrix, Inc). 
Detailed methods on analysis and software used can be found 
in the online-only Data Supplement.
Statistical Analysis 
Statistical analysis was performed using GraphPad Prism 7, 
Metaboanalyst, and the R program. Statistical parameters 
including the value of n (number of mice), the definition of 
center, dispersion and precision measures (mean±SEM or SD), 
and statistical significance is reported in the figures and fig-
ure legends. A P value of ≤0.05 was considered statistically 
significant. For direct comparisons, statistical significance was 
calculated by unpaired or paired Student t test. Multiple com-
parisons were assessed by 1-way or 2-way ANOVA followed 
by Bonferroni or Sidak multiple comparison tests, as appro-
priate. Details of the statistical analysis can be found in the 
online-only Data Supplement.
RESULTS
Exercise Promotes Physiological Cardiac 
Growth 
Wild-type mice subjected to 4 weeks of treadmill train-
ing showed a 48% increase in distance run and a 77% 
increase in work accomplished (Figure IA and IB in the 
online-only Data Supplement); successful exercise test-
ing was validated by elevated blood lactate levels, in-
dicating that the mice ran to exhaustion (Figure IC in 
the online-only Data Supplement). In comparison with 
untrained mice, trained mice had 15% higher levels of 
circulating plasma insulin-like growth factor-1 (Figure 
ID in the online-only Data Supplement), further dem-
onstrating systemic adaptation to the training regimen. 
Exercise-adapted mice displayed physiological car-
diac growth characterized by a 10% increase in heart 
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weight to tibia length (Figure  1A), a 24% increase in 
cardiomyocyte cross-sectional area, and a 35% increase 
in capillary-to-myocyte ratio (Figure  1B through 1D). 
Furthermore, exercise increased chamber diameter and 
wall thicknesses, improved indices of cardiac function 
(end-diastolic volume, stroke volume, and cardiac out-
put; Table I in the online-only Data Supplement), and 
activated the prohypertrophic signaling intermediate 
protein kinase B (AKT)19–23 (Figure  1E). Exercise train-
ing downregulated Cebpb and upregulated Cited4, an 
observation consistent with previous findings showing 
necessary involvement of these transcriptional media-
tors in regulating physiological growth.8,10–13 Moreover, 
the expression of Nfatc2, the deletion of which ame-
liorates pathological hypertrophy and heart failure 
but does not prevent physiological hypertrophy,24 was 
markedly lower in hearts from exercise-adapted mice 
(Figure 1F). Collectively, these results indicate that ex-
ercise training elicits robust cardiac adaptation in mice.
Metabolomic Changes in the Exercise-
Adapted Heart at Steady State 
To examine global metabolic changes in exercise-adapt-
ed hearts, we first compared the relative abundance 
of 424 metabolites in hearts isolated from sedentary 
and exercise-adapted mice. To capture the metabolic 
state of the adapted heart as accurately as possible, the 
hearts were freeze-clamped in situ 24 hours after the 
final exercise bout (Figure IIA in the online-only Data 
Supplement). Principal component analysis showed 
little separation between the groups (Figure IIB in the 
online-only Data Supplement), and only 20 metabolites 
(of 424 measured) were found to be significantly dif-
ferent (Figure IIC in the online-only Data Supplement). 
Of these, only 2 metabolites had a q value <0.05 (Table 
II in the online-only Data Supplement). These findings 
demonstrate that the steady-state abundance of most 
metabolites in the exercise-adapted heart is unchanged 
in comparison with that of sedentary mice.
Exercise Induces Periodicity in Glucose 
Metabolism 
Because the steady-state abundance of biochemical 
pathway intermediates may not be reflective of path-
way flux,17,25 and because several studies show that 
exercise changes cardiac metabolism (eg,22,26), we next 
measured the metabolism of [5-3H]glucose in hearts 
from sedentary and exercise-adapted mice. Radiomet-
ric assays of perfused hearts showed a nearly 2-fold 
increase in glucose utilization in exercise-adapted 
hearts in comparison with hearts from sedentary mice 
(Figure 2A). Glycolytic enzymes were found in similar 
abundance in exercise-adapted hearts relative to hearts 
from sedentary mice (Figure III in online-only Data Sup-
plement). These data indicate that changes in enzyme 
abundance are unlikely to contribute to the increase in 
glycolysis that occurs in the exercise-adapted heart.
Because glycolysis is influenced by rate-limiting 
steps, such as occurs at the phosphofructokinase reac-
tion, we next examined factors that regulate PFK1—
the rate-limiting and committed step of glycolysis.27, 28 
The PFK1 reaction exerts more control on glycolysis 
than any other step29 and is dependent on several fac-
tors including: the levels of fructose-2,6,-bisphosphate 
(F-2,6-P2), substrate availability, energy charge, the lev-
els of citrate and ATP, and pH. Because PFK2 regulates 
the levels of F-2,6-P2, a potent activator of PFK1, we 
examined the phosphorylation status of the myocardial 
isoform of PFK2, PFKFB2. Phosphorylation of PFKFB2 at 
S483 can increase F-2,6-P2 levels and is known to be 
under the influence of insulin-like growth factor-1/AKT 
signaling.20, 30-32 Notably, both cardiac AKT phosphory-
lation and plasma insulin-like growth factor-1 were el-
evated in exercise-adapted mice (Figure 1E and Figure 
ID in the online-only Data Supplement). In agreement 
with radiometric findings, S483 phosphorylation of 
PFKFB2 (p-PFK2) was 50% higher in exercise-adapted 
hearts compared with hearts of sedentary mice (Fig-
ure 2B, upper panel and Figure 2C, left panel). Taken 
Figure 1. Exercise training promotes physiological 
cardiac growth.  
Effect of treadmill training on the exercise-induced cardiac 
growth program. A, Gravimetric measurements of cardiac 
size (HW/TL, heart weight/tibia length). B, Representative 
myocardial sections stained with wheat germ agglutinin (red) 
and isolectin B4 (green). Nuclei are stained with DAPI (blue). 
C, Cardiomyocyte cross-sectional area. D, Capillary-to-
myocyte ratio. E, Phosphorylation of AKT (Ser473) 24 hours 
after the last training session. F, Relative mRNA expression 
of Cebpb, Cited4, and Nfatc2. Data are represented as 
mean±SEM. *P<0.05. **P<0.01. ***P<0.001. n=5–6 per 
group. DAPI indicates 4ʹ,6-diamidino-2-phenylindole; Exe, 
exercise; ISO, isolectin B4; Sed, sedentary; and WGA, wheat 
germ agglutinin.
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together, the radiometric and immunologic data pro-
vide convergent evidence that glycolysis is increased 
in the exercise-adapted heart and indicate that this in-
crease in glycolytic activity may be attributable at least 
in part to PFK activation.
Because exercise is a dynamic challenge that leads 
to rapid changes in metabolism, we next examined gly-
colytic changes that occur early after exercise, ie, in the 
trained state during recovery. Because ex vivo measure-
ments of flux in the recovery period after an exercise 
session are unlikely to provide meaningful data (eg, be-
cause of the lack of a metabolic steady state), we mea-
sured levels of p-PFK2 as a possible indicator of phos-
phofructokinase activity and glucose utilization through 
Figure 2. Exercise dynamically regulates glucose utilization in the heart.  
Measurements of glucose metabolism in the heart. A, Measurement of relative myocardial glucose utilization in isolated 
perfused hearts from mice that remained sedentary (Sed) or that were exercised for 4 weeks (Exe). Measurements were per-
formed on hearts excised 24 hours after the last exercise session. B, Representative immunoblots from a separate cohort of 
mice of S483 phosphorylation of the cardiac isoform of PFK2 (PFKFB2) in the sedentary (S) and the exercise-adapted (E) state: 
Upper, levels of PFK2 phosphorylation 24 hours after the last bout of exercise; Lower, PFK2 phosphorylation occurring 1 hour 
after the last exercise bout. C, Quantification of PFK2 phosphorylation from blots represented in B. D, Representative immu-
noblots of S483 phosphorylation of PFK2 in hearts of mice exercised for 1 day; these hearts were excised immediately after 
exercise, which would appear to be indicative of the state of PFK2 occurring during or immediately after exercise. E, Schematic 
representation of glycolysis showing relationship of PFK activity with glycogen storage. F, Myocardial glycogen content in 
hearts of Sed mice and in hearts excised immediately after 1 bout of exercise. Circulating levels of blood glucose (G), blood 
lactate (H), and plasma free fatty acids (FFA) (I) in mice subjected to a single bout of exercise. J, Schematic illustrating changes 
in glucose utilization occurring with acute and chronic exercise, ie, exercise-induced metabolic periodicity. Data are represented 
as mean±SEM. *P<0.05. **P<0.01. ****P<0.0001. n=5– 8 per group. DHAP indicates dihydroxyacetone phosphate; F-1,6-P2, 
fructose 1,6-bisphosphate; F6P, fructose 6-phosphate; G6P, glucose 6-phosphate; and GAP, glyceraldehyde-3-phosphate.
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glycolysis. In comparison with corresponding sedentary 
controls, hearts excised from exercise-adapted mice 1 
hour after the last exercise session showed significantly 
diminished PFK2 phosphorylation (Figure 2B, lower, and 
Figure 2C, right).
To determine whether these changes in metabolism 
precede cardiac adaptation, we eliminated the variable 
of extended training and examined PFK2 activation 
immediately after a single bout of exercise. For this, 
a separate group of mice was subjected to a single 
bout of exercise for 40 minutes. Immediately after this 
exercise bout, mice were euthanized and the hearts 
were excised for biochemical analysis. We found that 
p-PFK2 levels in these hearts were remarkably lower 
than those in sedentary controls (Figure 2D), suggest-
ing that a bout of exercise might acutely decrease the 
rate of glycolysis in the heart. Because measurement 
of glycolytic rate ex vivo would likely obfuscate the 
metabolic changes that occur during or shortly after 
a bout of exercise (because of the loss of hemody-
namic, metabolic, and paracrine [eg, catecholamine] 
influence), we chose to measure glycogen content as 
an additional surrogate of PFK activity and glycolysis. 
Thus, we hypothesized that, during exercise, PFK-
mediated decreases in glycolytic rate should promote 
glycogen accumulation (Figure  2E), which is consis-
tent with the notion that decreases in PFK activity pro-
mote glycogenesis.33 Indeed, glycogen content was 
elevated >5-fold in hearts collected immediately after 
a single bout of exercise (Figure 2F). It is noteworthy 
that this elevation in cardiac glycogen is not related to 
the short (6-hour) fasting period occurring in seden-
tary and exercised mice, because independent experi-
ments showed that fasting mice for this duration does 
not affect myocardial glycogen content (unfasted, 
0.17±0.03 µg/mg tissue; 6 hours fasted, 0.18±0.05 
µg/mg tissue; n=7–8 per group).
Because substrate availability and delivery are key 
determinants of myocardial substrate preference and 
utilization,34–37 we measured the circulating levels of 
glucose, lactate, and free fatty acids in mice immedi-
ately after a bout of exercise. In comparison with pre-
exercise levels, mice subjected to 40 minutes of tread-
mill exercise showed a 50% decrease in blood glucose 
and a 2.5-fold increase in blood lactate (Figure  2G 
and 2H). Moreover, plasma free fatty acids were sig-
nificantly elevated (Figure  2I), which along with the 
changes in blood glucose and lactate, would stimu-
late lactate and fat oxidation and diminish overall glu-
cose utilization. These data are concordant with our 
biochemical measurements and provide convergent 
evidence suggesting that, during and immediately af-
ter exercise, the rate of myocardial glycolysis is dimin-
ished; however, on adaptation and full recovery, the 
steady-state rates of glycolysis appear to be increased 
in the heart (Figure 3J).
Phosphofructokinase Is a Strong 
Regulator of the Glucose–Fatty Acid 
Cycle in the Heart 
We next examined whether exercise-induced periodic-
ity in glucose metabolism might be essential for struc-
tural and functional cardiac adaptation. This hypothesis 
is consistent with the notion that repetitive bouts of 
exercise are a trigger for the transcriptional adaptation 
in skeletal muscle.2 As tools to examine the relationship 
between changes in myocardial glucose metabolism 
and cardiac remodeling, we used genetically modified 
mice expressing kinase-deficient (GlycoLo) or phospha-
tase-deficient (GlycoHi) point-mutant isoforms of PFK2 
under the control of the α-myosin heavy chain promoter, 
which constitutively decrease or increase PFK1 activity 
and myocardial glycolytic rate.14,15 In comparison with 
cardiomyocytes isolated from WT mice, the abundance 
of F-2,6-P2 was >2-fold lower in Glyco
Lo cardiomyo-
cytes and >5-fold higher in GlycoHi cardiomyocytes (Fig-
ure 3A). The rate of glycolysis in perfused hearts was 
in accordance with transgene-induced alterations in 
F-2-6-P2 (Figure  3B). Consistent with the notion that 
PFK activity regulates glycogen storage,33 GlycoLo hearts 
showed 1.6-fold higher myocardial glycogen content, 
and GlycoHi hearts demonstrated 4-fold lower levels of 
glycogen (Figure 3C).
To determine how glycolysis affects myocardial me-
tabolism, we measured the steady-state abundance 
of myocardial metabolites in both GlycoLo and GlycoHi 
hearts (Figure 3D). Principal component analysis showed 
that the relative abundances of metabolites could dis-
criminate between the genotypes (Figure 3E). Volcano 
plot analysis demonstrated that, of the 424 metabolites 
measured, 108 metabolites in GlycoLo hearts (Figure 
IVA and Table III in the online-only data supplement) 
and 109 metabolites in GlycoHi hearts (Figure IVB and 
Table IV in the online-only Data Supplement) were sig-
nificantly different from WT hearts. Visualization of 
changes in the metabolic network demonstrated the 
greatest impact on the lipid superfamily, with acylcar-
nitines (subfamily 1) showing robust, diametrically op-
posite changes in the GlycoLo and GlycoHi hearts (Fig-
ure 3F and 3G). Z-score analyses illustrate remarkable 
increases in medium- and long-chain acylcarnitines in 
GlycoHi hearts; the corresponding species were lower 
in abundance in GlycoLo hearts (Figure VA and Tables 
III and IV in the online-only Data Supplement). In addi-
tion, long-chain fatty acids (saturated and unsaturated) 
were lower in GlycoLo mice, whereas many of the same 
species were elevated in GlycoHi mice (Figure 3F and 3G, 
Figure VA and Tables III and IV in the online-only Data 
Supplement). It is interesting to note that GlycoLo hearts 
demonstrated elevated levels of aconitate, homocitrate, 
and α-ketoglutarate (Figure 3F and 3G and Table III in 
the online-only Data Supplement), suggesting that high 
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rates of lipid oxidation in these hearts might flood the 
Krebs cycle. Glycolytic intermediates were lower in Gly-
coHi mice, whereas most glycolytic intermediates were 
unchanged in abundance in GlycoLo mice (Figure  3F 
and 3G and Figure VB in the online-only Data Sup-
plement). Changes in the steady-state abundances of 
Figure 3. Cardiac F-2,6-P2 regulates myocardial glucose and lipid metabolism. 
Metabolic phenotyping of GlycoLo and GlycoHi mice. A, Levels of F-2,6-P2 in cardiomyocytes isolated from WT, Glyco
Lo, and 
GlycoHi mice. n=3 to 6 per group. B, Relative myocardial glucose utilization in isolated perfused hearts. n=5 to 7 per group. C, 
Myocardial glycogen content. n=7 to 9 per group. D, Schematic of metabolomic analysis of WT, GlycoLo, and GlycoHi hearts. 
E, 2D PCA analysis. F, Metabolic network visualization of metabolites in GlycoLo and GlycoHi hearts in comparison with cor-
responding WT hearts. Circle size is indicative of the magnitude of change (blue and red circles indicate significantly decreased 
or increased metabolite abundance in comparison with WT controls, respectively). Numbers represent metabolites in the 
following subpathways: 1, acylcarnitines; 2, monacylglycerols; 3, monohydroxy fatty acids; 4, phospholipid metabolism; 5, 
lysolipids; 6, polyunsaturated fatty acids; 7, sphingolipids; 8, dicarboxylic fatty acids; 9, long-chain fatty acids; 10, glycolysis; 
11, fructose, mannose, galactose metabolism; 12, pentose metabolism; 13, TCA cycle; 14, purine metabolism, (hypo)xan-
thine/inosine; 15, purine metabolism, adenine; 16, Gly, Ser, Thr metabolism; 17, BCAA metabolism; 18, Met, Cys, SAM, Tau 
metabolism. G, Overview of changes in major metabolic subpathways in GlycoLo and GlycoHi hearts (F). *P<0.05. **P<0.01. 
***P<0.001. ****P<0.0001 versus the indicated group. BCAA indicates branched-chain amino acid; F-2,6-P2, fructose 
2,6,-bisphosphate; LC/MS/MS, liquid chromatography/tandem mass spectrometry; PCA, principal component analysis; SAM, 
S-adenosyl methionine; TCA, tricarboxylic acid; and WT, wild type.
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glycolytic and lipid metabolites are most consistent with 
increased propensity for glucose oxidation in GlycoHi 
hearts and increased lipid oxidation in GlycoLo hearts. 
These changes would be sufficient to explain the ac-
cumulation of acylcarnitines and diminished levels of 
glycolytic intermediates occurring in GlycoHi hearts, 
and the lower levels of acylcarnitines in GlycoLo hearts. 
Polarization of myocardial metabolism also resulted in 
modest changes in amino acid metabolites (see Figure 
VC and Tables III and IV in the online-only Data Supple-
ment). Collectively, these results show the high degree 
to which phosphofructokinase regulates the glucose–
fatty acid cycle in the heart.
Constitutively Low Glycolytic Activity 
Promotes Structural and Transcriptional 
Changes Consistent With the Exercise-
Adapted Heart 
To examine whether PFK activity regulates cardiac 
growth, we assessed the structure and function of 
GlycoLo and GlycoHi hearts. Both the GlycoLo and GlycoHi 
hearts showed a mild increase in cardiac size, which 
was associated with increased cardiomyocyte cross-sec-
tional area (Figure 4A through 4C, 4E, and 4F); how-
ever, significantly increased capillary-to-myocyte ratio 
was observed only in GlycoLo hearts (Figure 4A and 4D). 
Picrosirius red staining showed no noteworthy myocar-
dial fibrosis in either strain (Figure 4A). It is interesting 
to note that GlycoLo hearts showed elevated end-dia-
stolic volume and slightly increased wall thicknesses in 
comparison with WT mice (Table V in the online-only 
Data Supplement), which is similar to that found in 
WT, exercise-adapted mice (see Table I in the online-
only Data Supplement). In contrast, GlycoHi hearts had 
elevated end-systolic volume, lower ejection fraction, 
and larger chamber diameters, suggesting a more di-
lated cardiac phenotype (Table V in the online-only Data 
Supplement).
To determine whether the signaling mediators and 
transcriptional programs underlying exercise-induced 
cardiac growth10–12,38 are affected by constitutive changes 
Figure 4. Constitutive changes in glycolysis promote cardiac growth and hypertrophy.  
Structural and molecular indices of cardiac growth/hypertrophy. A, Representative myocardial sections stained for: Left, wheat 
germ agglutinin (red), isolectin B4 (green), and DAPI (blue); and Right, Picrosirius red. B and E, Gravimetric measurement of 
cardiac size (HW/TL, heart weight/tibia length). C and F, Cardiomyocyte cross-sectional area. D and G, Capillary-to-myocyte 
ratio. H, Basal phosphorylation of AKT (Ser473). I and J, Relative mRNA expression of genes associated with the physiological 
growth program. Data are represented as mean±SEM. *P<0.05. **P<0.01. ***P<0.001. ****P<0.0001. n=6 to 12 per group. 
DAPI indicates 4ʹ,6-diamidino-2-phenylindole; ISO, isolectin B4; WGA, wheat germ agglutinin; and WT, wild type.
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in glucose utilization, we next examined the phosphor-
ylation of AKT and the relative expression of Cebpb and 
Cited4. Although no differences in basal p-AKT (S473) 
were observed in either strain (Figure 4H), Cebpb ex-
pression was lower and Cited4 expression was higher 
in GlycoLo hearts than in WT counterparts (Figure 4I). 
Expression of these genes was unchanged in GlycoHi 
hearts (Figure 4J). Although Nfatc2 showed a trend to-
ward lower expression in GlycoLo hearts, this did not 
reach statistical significance. These data suggest that 
constitutively low or high rates of glycolysis cause mild 
cardiac hypertrophy and that a low rate of glycolysis, in 
the absence of AKT activation, is sufficient to promote 
a structural, functional, and transcriptional phenotype 
resembling the exercise-adapted heart.
Metabolic Inflexibility Causes 
Mitochondrial Structural and Functional 
Abnormalities 
Because constitutive polarization of metabolism toward 
either glucose or fat oxidation could have deleterious 
effects on mitochondrial structure and function, we 
examined mitochondrial ultrastructure by transmission 
electron microscopy and measured respiration in mito-
chondria isolated from the hearts of both GlycoLo and 
GlycoHi mice. As shown in Figure 5A, qualitative analy-
sis of electron micrographs showed disorganization of 
mitochondrial cristae and diminished cristae density in 
comparison with WT littermates. Consistent with this 
observation, mitochondria from both GlycoLo and Gly-
coHi hearts showed lower respiration in the presence 
of pyruvate+malate or succinate (Figure  5B and 5C). 
In addition, respiratory control ratios were found to 
be lower in cardiac mitochondria from both transgenic 
strains, suggesting diminished coupling of mitochon-
drial electron transport to ATP synthesis (Figure  5D). 
Thus, although constitutively low glycolysis imparts 
some structural, functional, and transcriptional fea-
tures characteristic of the exercise-adapted heart, the 
mitochondrial compartment is damaged by metabolic 
inflexibility.
Constitutively Low Glycolysis Is Sufficient 
for Maximal Cardiac Growth 
With the observation that GlycoLo hearts have a cardiac 
phenotype partially resembling the exercise-adapted 
Figure 5. Metabolic inflexibility disrupts cristae structure and causes mitochondrial dysfunction.  
A, Electron micrographs of WT, GlycoLo, and GlycoHi hearts. Arrows indicate areas of decreased cristae organization and density in 
comparison with WT controls. State 3 (B) and State 4 (C) respiration in isolated cardiac mitochondria measured by using complex I 
(pyruvate+malate)– and complex II (succinate)–specific substrates. D, Respiratory control ratios. Data are represented as mean±SEM. 
*P<0.05. **P<0.01. n=3 per group. OCR indicates oxygen consumption rate; RCR, respiratory control ratio; and WT, wild type
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heart, we next asked whether these mice are capable of 
performing more work or adapting to a greater degree 
than their WT counterparts. To address this question, we 
subjected both WT and GlycoLo mice to exercise testing 
before and after 4 weeks of treadmill training. Although 
GlycoLo mice were able to adapt systemically to the train-
ing regimen, they were not able to run farther or perform 
more work than WT mice (Figure 6A and 6B). Unlike WT 
mice, which showed a ≈15% increase in cardiac size, Gly-
coLo mice showed no further increase in cardiac growth 
after training (Figure 6C). Similarly, myocardial expression 
of Cebpb and Cited4 were not found to be different in 
exercised GlycoLo mice than in sedentary GlycoLo mice 
(Figure 6D), suggesting that their baseline cardiac phe-
notype is sufficient to meet the increased cardiovascular 
demands brought about by exercise. These results sug-
gest that a constitutively low glycolytic rate is sufficient to 
maximally activate physiological cardiac growth.
Because exercise could have beneficial effects on mi-
tochondrial function,23 we next posited that it might 
restore mitochondrial function in GlycoLo hearts. In WT 
mice, exercise did not affect state 3 respiration in the 
presence of any substrate tested, and, in GlycoLo mice, 
exercise did not reverse mitochondrial dysfunction 
caused by their metabolic phenotype (Figure 6E).
Glycolysis Regulates Gene Expression in 
the Heart 
To gain further insight into the extent to which gly-
colysis might regulate myocardial gene expression, we 
assessed relative transcript abundance in GlycoLo and 
GlycoHi hearts. Results of Genechip arrays showed that 
the expression of 619 genes were significantly different 
in GlycoLo and GlycoHi hearts in comparison with hearts 
of corresponding WT mice (Up: GlycoLo, 7; GlycoHi, 309; 
Down: GlycoLo, 22; GlycoHi, 295 genes; 14 differential-
ly expressed genes overlapped in GlycoLo and GlycoHi 
hearts). As shown in Figure VIA in the online-only Data 
Supplement, the top 100 genes include genes critical 
for intermediary metabolism, neurotransmission and 
ion channel activity/transport, DNA damage/repair, cell 
proliferation/differentiation, cell signaling, gene tran-
scription, inflammation and stress responses, detoxi-
fication and xenobiotic metabolism, and cytoskeletal/
contractile function. In particular, we were interested 
in genes that are differentially regulated by glycolysis, 
ie, affected in diametric opposition with respect to low 
or high glycolytic activity (Figure VIB in the online-only 
Data Supplement). In addition to Cited4, we found that 
glycolysis regulates the expression of genes involved in 
Figure 6. Low myocardial glycolytic rates are sufficient for maximal cardiac growth. 
Effects of exercise training on exercise capacity, cardiac growth, and mitochondrial function in WT and GlycoLo mice. Pre- and 
posttraining distance (A) and work (B). C, Percent cardiac growth in exercise-adapted (Exe) mice in comparison with sedentary 
(Sed) controls. n=10 to 11 per group. D, Relative mRNA expression of genes associated with the physiological growth pro-
gram. n=5 per group. E, State 3 respiration in isolated cardiac mitochondria using complex I (pyruvate+malate)–, complex II 
(succinate)–, and fatty acid oxidation (palmitoylcarnitine+malate)–specific substrates. n=3 per group. Data are represented as 
mean±SEM. *P<0.05. ****P<0.0001. WT indicates wild type.
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one-carbon metabolism and downstream methylation 
reactions (Pah, Phgdh, Mtr), lipid metabolism (Insg1, 
Angptl3), gluconeogenic activity (Fbp2), cell division 
(Cenpf), osmoregulation (Cenpf, Aqp4), transcription 
(Tox3), G-protein signaling (Ramp1), calcium-related 
processes (Rcan1, Cacna1g). Gene ontology analysis 
showed that low rates of glycolysis had a strong influ-
ence on genes involved in oxidation-reduction process-
es, lipid metabolism, and responses to cAMP (Figure 
VIC in the online-only Data Supplement). High glyco-
lytic rates also influenced genes involved in metabolism, 
responses to cAMP, responses to hormonal stimuli, and 
transcription. In addition, genes involved in angio-
genesis and differentiation, showed highly significant 
changes (Figure VID in the online-only Data Supple-
ment). Collectively, the findings of this study indicate 
that the activity of phosphofructokinase has pervasive 
effects on the metabolic, transcriptional, structural, and 
functional characteristics of the adult heart.
DISCUSSION
In this study, we provide evidence suggesting that ex-
ercise dynamically regulates myocardial glycolytic activ-
ity at the level of phosphofructokinase. To assess the 
importance of exercise-induced periodicity in glucose 
metabolism, we used transgenic mice expressing mu-
tant transgenes that constitutively increase or decrease 
phosphofructokinase activity in the heart. Expression of 
a dominant-negative form of PFK2 (GlycoLo) in the heart 
decreased glycolytic rate and was sufficient to modu-
late the Cebpb/Cited4 transcriptional program that reg-
ulates physiological cardiac growth.11–13 Mice in which 
myocardial glycolytic rate is constitutively high also 
showed slight hypertrophy, but these hearts did not en-
gage the physiological growth gene program. The cor-
ollary of these findings is that exercise-induced changes 
in phosphofructokinase activity are necessary to acti-
vate transcriptional programs dictating cardiac growth 
and hypertrophy. This is supported by our transcrip-
tomics data from both GlycoLo mice and GlycoHi mice, 
which revealed coordinated regulation of not only the 
Cited4 gene, but also genes important for epigenetic 
regulation, lipid metabolism, gluconeogenic activity, 
contractility, and angiogenesis. Nevertheless, constitu-
tive changes in myocardial metabolism incited damage 
to the mitochondrial compartment. Collectively, these 
results suggest that episodic decreases in glycolytic ac-
tivity caused by exercise are required for physiological 
cardiac remodeling and that metabolic flexibility is im-
portant to maintain mitochondrial health in the heart.
Our findings in the heart are reminiscent of exercise-
induced changes in skeletal muscle, where transient 
and repetitive changes in gene expression, likely initi-
ated by acute disruption of metabolic equanimity dur-
ing exercise, stimulate adaptation.2 Although testing 
the role of metabolic periodicity in the heart is difficult, 
the posttranslational regulation of PFK2 that we found 
to occur with exercise provided a unique opportunity to 
test not only how glucose utilization affects the cardiac 
phenotype, but also how restricting fuel flexibility regu-
lates cardiac structure, function, and gene expression. 
The dominant-negative approach to overcome the ac-
tivity of endogenous myocardial PFK2, ie, expression of 
the kinase-deficient form of PFK2, was sufficient to trig-
ger a physiological cardiac growth phenotype: GlycoLo 
hearts showed lower Cebpb and higher Cited4 expres-
sion, which mirrored the transcriptional changes found 
in the exercise-adapted heart. This transcriptional sig-
nature was complemented by a cardiac growth phe-
notype replete with enlarged myocytes and increased 
capillary density. In addition, the chamber volumes, wall 
thicknesses, and functional values of GlycoLo hearts 
were nearly identical to that found in exercise-adapted 
hearts. GlycoLo hearts appear to have a maximal func-
tional and structural physiological growth phenotype 
because they could not further activate the physiologi-
cal growth gene program or undergo additional car-
diac growth in response to the exercise regimen. It is 
important to note that the phenotype of GlycoLo hearts 
developed in the absence of AKT activation, which has 
been suggested to underlie exercise-induced downreg-
ulation of Cebpb and upregulation of Cited4 and the 
general cardiac growth phenotype.9,10 Thus, these data 
help form a model in which exercise-induced modula-
tion of glucose metabolism is a proximal regulator of 
physiological cardiac growth.
Several factors appear to contribute to acute, exer-
cise-induced decreases in glycolysis and phosphofructo-
kinase activity. The lower circulating blood glucose lev-
els and increased levels of blood lactate and free fatty 
acids that we found to occur immediately after a single 
bout of exercise suggest diminished glycolytic activity 
occurring in the heart during and in the early recovery 
period after exercise. Indeed, lactate and fatty acids are 
preferred substrates of the heart that suppress glucose 
utilization both in vivo34,39,40 and ex vivo.36,37 Moreover, 
previous studies in humans and animal models suggest 
that changes in these substrates during exercise contrib-
ute to diminished exercise oxygen extraction ratios for 
glucose and lower glucose uptake and utilization.41,42 
Not only do increases in circulating lactate and fatty ac-
ids with exercise appear to favor lower rates of glucose 
utilization, they also divert glucose from glycolysis to 
glycogen synthesis, which is thought to be caused in 
part by diminished phosphofructokinase activity.43–45 
Consistent with this idea, our results show diminished 
phosphorylation of S483 of PFK2 and increased levels 
of glycogen, which support the hypothesis that PFK1 
activity and glycolysis are diminished with prolonged 
exercise or during the early recovery period. In the con-
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text of glucose utilization, changes in PFK1 are particu-
larly important because this node of metabolism rep-
resents the major control point of glycolysis, exerting 
65% control over flux through the pathway.29
Although constitutively low glycolytic rates appeared 
sufficient to drive physiological growth, metabolic in-
flexibility in both the GlycoHi and GlycoLo hearts appeared 
sufficient to cause some pathology as well. Although 
GlycoHi hearts were enlarged, they did not demonstrate 
significantly increased capillary-to-myocyte ratios, and, 
functionally, they presented with a mildly diminished 
ejection fraction, significantly higher end-systolic vol-
ume, and larger chamber diameters. These findings 
are in agreement with previous studies15 and suggest 
that chronically high rates of glycolysis promote a more 
pathological form of hypertrophy. Furthermore, that 
mitochondria isolated from both GlycoHi and GlycoLo 
hearts showed mitochondrial dysfunction suggests that 
deleterious changes in mitochondria occurring in the 
heart in the context of type 2 diabetes mellitus or heart 
failure, conditions associated with excessive myocardial 
reliance on fatty acids or glucose, respectively,46,47 could 
in part be caused by severe metabolic inflexibility. Al-
though genetic downregulation of Cebpb and upregu-
lation of Cited4 protect against pathological insults,11,12 
mice with constitutively low glycolysis subjected to pres-
sure overload display exacerbated pathological remod-
eling,48 which we suggest may be attributable to poor 
mitochondrial health caused by metabolic inflexibility.
Although at steady state the exercise-adapted heart 
showed higher glycolytic activity, we found relatively 
few changes in metabolite abundance. We speculate 
that higher myocardial metabolic flux in the absence 
of changes in the steady-state abundance of metabo-
lites may be an indication of a physiological form of 
metabolic remodeling that occurs in the exercise-
adapted heart. However, it should be noted that our 
results contrast somewhat with a previous finding that 
showed modestly lower abundances of acylcarnitines 
and organic acids in hearts of female mice adapted to 2 
months of voluntary wheel running.49 The discrepancy 
between these 2 studies could be attributable to sex 
differences, strain differences, differences in the train-
ing modality, and intensity. Moreover, given the high 
energy utilization of the heart, even slightly different 
methods of handling the samples prior to freezing may 
in part explain differences in metabolomics results.
Although our data support the idea that PFK-mediat-
ed modulation of metabolism influences transcriptional 
programs relating to cardiac growth and remodeling, it is 
possible that fat utilization or lactate oxidation, which are 
regulated in concert with glucose metabolism, are also 
important triggers of cardiac adaptation. Future studies 
to determine how exercise acutely changes the cardiac 
metabolome could help answer whether changes in me-
tabolites in each pathway during or shortly after exercise 
promote biofeedback that coordinates transcriptional 
programming. Moreover, identifying how exercise inten-
sity and duration regulate cardiac metabolism and gene 
transcription would be important for optimizing cardiac 
adaptations and for further understanding links between 
metabolism and cardiac growth. Particularly intriguing is 
the question of how such changes in metabolism may 
regulate epigenetic modifications. In our study, we found 
that glycolysis regulated Phgdh, Mthfd2, and Mtr, which 
code for proteins critical for serine biosynthesis, 1-carbon 
metabolism, and methylation reactions. This could be 
significant because Cited4 is epigenetically regulated: hy-
permethylation of Cited4-associated CpG islands causes 
lower expression of Cited4 in oligodendroglial tumors.50 
Although our data do not address this mechanism, they 
suggest that low glycolytic rates could prevent such 
methylation events, thereby permitting Cited4 transcrip-
tion, especially when appropriate stimuli are present.
In summary, our results indicate that low rates of 
glycolysis during or shortly after exercise regulate gene 
programs important for cardiac growth and that invari-
antly high rates of glycolysis promote a more pathologi-
cal form of hypertrophy. Although metabolic inflexibility 
is damaging to mitochondria, changes in glucose utili-
zation attributable to regular exercise appear to be im-
portant to maintain mitochondrial health and to derive 
maximal cardiac benefits from physical activity. In ad-
dition, by integrating metabolomic and transcriptomic 
data, these studies provide new insights into how PFK-
mediated changes in metabolism regulate gene expres-
sion in the heart. Additional work is needed to further 
disclose how exercise-mediated changes in metabolism 
regulate gene transcription and tissue remodeling and 
how these changes could be targeted to maximize the 
beneficial cardiovascular effects of exercise.
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